Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Rothenberg

Showing results (491-500 of 658) with videos related to

Pageof 66
Sort By:
Biorxiv : the Preprint Server for Biology|October 14, 2020
Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2Nurit P Azouz, Andrea M Klingler, Victoria Callahan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2016
Control of inflammation by stromal Hedgehog pathway activation restrains colitisJohn J Lee, Michael E Rothenberg, E Scott Seeley, et al.
The Journal of Experimental Medicine|December 10, 2009
Intestinal epithelial cell secretion of RELM-beta protects against gastrointestinal worm infectionDe'Broski R Herbert, Jun-Qi Yang, Simon P Hogan, et al.
Pathogens & Immunity|May 10, 2021
Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2Nurit P Azouz, Andrea M Klingler, Victoria Callahan, et al.
Clinical and Translational Science|August 19, 2023
A phase I, randomized, ascending-dose study to assess safety, pharmacokinetics, and activity of GDC-8264, a RIP1 inhibitor, in healthy volunteersNicholas S Jones, Smita Kshirsagar, Vishnu Mohanan, et al.
Immunological Reviews|April 9, 2001
Elemental signals regulating eosinophil accumulation in the lungP S Foster, A W Mould, M Yang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 25, 2008
Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic casesMargaret H Collins, Carine Blanchard, J Pablo Abonia, et al.
Antimicrobial Agents and Chemotherapy|March 27, 2019
A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-<i>Staphylococcus aureus</i> Thiomab Antibody-Antibiotic Conjugate, in Healthy VolunteersMelicent Peck, Michael E Rothenberg, Rong Deng, et al.
The Journal of Allergy and Clinical Immunology|December 31, 2011
Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trialJonathan M Spergel, Marc E Rothenberg, Margaret H Collins, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|February 10, 2016
Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoringM H Collins, L J Martin, E S Alexander, et al.
Pageof 66

Showing results (491-500 of 658) with videos related to

Sort By:
Pageof 66
Biorxiv : the Preprint Server for Biology|October 14, 2020
Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2Nurit P Azouz, Andrea M Klingler, Victoria Callahan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2016
Control of inflammation by stromal Hedgehog pathway activation restrains colitisJohn J Lee, Michael E Rothenberg, E Scott Seeley, et al.
The Journal of Experimental Medicine|December 10, 2009
Intestinal epithelial cell secretion of RELM-beta protects against gastrointestinal worm infectionDe'Broski R Herbert, Jun-Qi Yang, Simon P Hogan, et al.
Pathogens & Immunity|May 10, 2021
Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2Nurit P Azouz, Andrea M Klingler, Victoria Callahan, et al.
Clinical and Translational Science|August 19, 2023
A phase I, randomized, ascending-dose study to assess safety, pharmacokinetics, and activity of GDC-8264, a RIP1 inhibitor, in healthy volunteersNicholas S Jones, Smita Kshirsagar, Vishnu Mohanan, et al.
Immunological Reviews|April 9, 2001
Elemental signals regulating eosinophil accumulation in the lungP S Foster, A W Mould, M Yang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 25, 2008
Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic casesMargaret H Collins, Carine Blanchard, J Pablo Abonia, et al.
Antimicrobial Agents and Chemotherapy|March 27, 2019
A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-<i>Staphylococcus aureus</i> Thiomab Antibody-Antibiotic Conjugate, in Healthy VolunteersMelicent Peck, Michael E Rothenberg, Rong Deng, et al.
The Journal of Allergy and Clinical Immunology|December 31, 2011
Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trialJonathan M Spergel, Marc E Rothenberg, Margaret H Collins, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|February 10, 2016
Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoringM H Collins, L J Martin, E S Alexander, et al.
Pageof 66